Bartlett & Co Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-50
| Closed | -$9.19K | – | 1093 |
|
2021
Q2 | $9.19K | Hold |
50
| – | – | ﹤0.01% | 703 |
|
2021
Q1 | $7.65K | Hold |
50
| – | – | ﹤0.01% | 758 |
|
2020
Q4 | $7.81K | Hold |
50
| – | – | ﹤0.01% | 757 |
|
2020
Q3 | $5.72K | Hold |
50
| – | – | ﹤0.01% | 724 |
|
2020
Q2 | $5.61K | Hold |
50
| – | – | ﹤0.01% | 730 |
|
2020
Q1 | $4.49K | Hold |
50
| – | – | ﹤0.01% | 732 |
|
2019
Q4 | $5.41K | Hold |
50
| – | – | ﹤0.01% | 758 |
|
2019
Q3 | $4.9K | Hold |
50
| – | – | ﹤0.01% | 778 |
|
2019
Q2 | $6.55K | Hold |
50
| – | – | ﹤0.01% | 615 |
|
2019
Q1 | $6.76K | Hold |
50
| – | – | ﹤0.01% | 601 |
|
2018
Q4 | $4.87K | Hold |
50
| – | – | ﹤0.01% | 620 |
|
2018
Q3 | $6.95K | Hold |
50
| – | – | ﹤0.01% | 621 |
|
2018
Q2 | $6.21K | Hold |
50
| – | – | ﹤0.01% | 625 |
|
2018
Q1 | $5.57K | Buy |
+50
| New | +$5.57K | ﹤0.01% | 650 |
|